Search Results - "Binetti, G."

Refine Results
  1. 1

    Role of Probiotics, Prebiotics, and Synbiotics in the Elderly: Insights Into Their Applications by Ale, Elisa C, Binetti, Ana G

    Published in Frontiers in microbiology (28-01-2021)
    “…Elderly people are an important part of the global population who suffer from the natural processes of senescence, which lead to changes in the gut microbiota…”
    Get full text
    Journal Article
  2. 2

    Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration by GHIDONI, R, BENUSSI, L, GLIONNA, M, FRANZONI, M, BINETTI, G

    Published in Neurology (14-10-2008)
    “…Mutations in the progranulin gene (PGRN) were identified as the causal mechanism underlying frontotemporal lobar degeneration (FTLD). Most of these mutations…”
    Get full text
    Journal Article
  3. 3

    Conversion from mild cognitive impairment to Alzheimer’s disease is predicted by sources and coherence of brain electroencephalography rhythms by Rossini, P.M., Del Percio, C., Pasqualetti, P., Cassetta, E., Binetti, G., Dal Forno, G., Ferreri, F., Frisoni, G., Chiovenda, P., Miniussi, C., Parisi, L., Tombini, M., Vecchio, F., Babiloni, C.

    Published in Neuroscience (01-12-2006)
    “…Objective. Can quantitative electroencephalography (EEG) predict the conversion from mild cognitive impairment (MCI) to Alzheimer’s disease (AD)? Methods…”
    Get full text
    Journal Article
  4. 4

    Different types of abstract concepts: evidence from two neurodegenerative patients by Catricalà, E., Conca, F., Borsa, V.M., Cotelli, M., Manenti, R., Gobbi, E., Binetti, G., Cotta Ramusino, M., Perini, G., Costa, A., Rusconi, M.L., Cappa, S.F.

    Published in Neurocase (04-05-2021)
    “…The observation of neurological patients showing selective impairments for specific conceptual categories contributed in the development of semantic memory…”
    Get full text
    Journal Article
  5. 5

    Longitudinal prognostic value of serum free copper in patients with Alzheimer disease by SQUITTI, R, BRESSI, F, ROSSINI, P. M, PASQUALETTI, P, BONOMINI, C, GHIDONI, R, BINETTI, G, CASSETTA, E, MOFFA, F, VENTRIGLIA, M, VERNIERI, F

    Published in Neurology (06-01-2009)
    “…Serum copper not bound to ceruloplasmin ("free") appears slightly elevated in patients with Alzheimer disease (AD). We explored whether a deregulation of the…”
    Get full text
    Journal Article
  6. 6

    MCI patients’ EEGs show group differences between those who progress and those who do not progress to AD by Moretti, D.V, Frisoni, G.B, Fracassi, C, Pievani, M, Geroldi, C, Binetti, G, Rossini, P.M, Zanetti, O

    Published in Neurobiology of aging (01-04-2011)
    “…Abstract The theta/gamma and alpha3/alpha2 ratio were investigated as early markers for prognosticating of progression to dementia. 76 subjects with mild…”
    Get full text
    Journal Article
  7. 7

    Photocatalytic NOx removal with TiO2-impregnated 3D-printed PET supports by Binetti Basterrechea, G.F., Montesinos, V.N., Quici, N.

    Published in Heliyon (01-12-2023)
    “…In this work, we investigated the photocatalytic removal of NOx using 3D-printed supports. Monolithic supports with internal channels were fabricated by Fused…”
    Get full text
    Journal Article
  8. 8

    EEG markers are associated to gray matter changes in thalamus and basal ganglia in subjects with mild cognitive impairment by Moretti, D.V., Paternicò, D., Binetti, G., Zanetti, O., Frisoni, G.B.

    Published in NeuroImage (Orlando, Fla.) (01-03-2012)
    “…Gray matter (GM) changes of thalamus and basal ganglia have been demonstrated to be involved in Alzheimer's disease (AD). Moreover, the increase of two EEG…”
    Get full text
    Journal Article
  9. 9

    Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease by Ventriglia, M, Bocchio Chiavetto, L, Benussi, L, Binetti, G, Zanetti, O, Riva, M A, Gennarelli, M

    Published in Molecular psychiatry (01-01-2002)
    “…MOLECULAR PSYCHIATRY: (2002) 7, 136-139. DOI: 10.1038/sj.mp.4000952…”
    Get full text
    Journal Article
  10. 10

    Action and Object Naming in Frontotemporal Dementia, Progressive Supranuclear Palsy, and Corticobasal Degeneration by Cotelli, M, Borroni, B, Manenti, R, Alberici, A, Calabria, M, Agosti, C, Arévalo, A, Ginex, V, Ortelli, P, Binetti, G, Zanetti, O, Padovani, A, Cappa, S. F

    Published in Neuropsychology (01-09-2006)
    “…Action naming has been reported to be disproportionately impaired in comparison to object naming in patients with frontotemporal dementia (FTD). This finding…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Quantitative EEG Markers in Mild Cognitive Impairment : Degenerative versus Vascular Brain Impairment by Moretti, D. V., Zanetti, O., Binetti, Giuliano, Frisoni, Giovanni B.

    “…We evaluated the relationship between brain rhythmicity and both the cerebrovascular damage (CVD) and amygdalohippocampal complex (AHC) atrophy, as revealed by…”
    Get full text
    Journal Article
  13. 13

    Mapping the effect of APOE ε4 on gray matter loss in Alzheimer's disease in vivo by Pievani, M., Rasser, P.E., Galluzzi, S., Benussi, L., Ghidoni, R., Sabattoli, F., Bonetti, M., Binetti, G., Thompson, P.M., Frisoni, G.B.

    Published in NeuroImage (Orlando, Fla.) (01-05-2009)
    “…Previous studies suggest that in Alzheimer's disease (AD) the Apolipoprotein E ( APOE) ε4 allele is associated with greater vulnerability of medial temporal…”
    Get full text
    Journal Article
  14. 14

    Non-ergot dopamine agonist rotigotine as a promising therapeutic tool in atypical parkinsonism syndromes: A 24 months pilot observational open-label study by Moretti, D.V., Binetti, G., Zanetti, O., Frisoni, G.B.

    Published in Neuropharmacology (01-10-2014)
    “…Rotigotine (RTG) is a non-ergot dopamine agonist developed as a new transdermal formulation, indicated for use in early and advanced Parkinson's disease (PD)…”
    Get full text
    Journal Article
  15. 15

    Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment by Geroldi, C, Rossi, R, Calvagna, C, Testa, C, Bresciani, L, Binetti, G, Zanetti, O, Frisoni, G B

    “…Background: The diagnosis of mild cognitive impairment (MCI) is clinically unhelpful, as many patients with MCI develop dementia but many do not. Objective: To…”
    Get full text
    Journal Article
  16. 16

    Specific EEG Changes Associated with Atrophy of Hippocampus in Subjects with Mild Cognitive Impairment and Alzheimer's Disease by Fracassi, C., Moretti, D. V., Frisoni, Giovanni B., Zanetti, O., Binetti, Giuliano, Prestia, A.

    “…We evaluated the association between hippocampal atrophy and increase of the EEG markers alpha3/alpha2 relative power ratio in mild cognitive impairment (MCI)…”
    Get full text
    Journal Article
  17. 17

    Increase of theta/gamma ratio is associated with memory impairment by Moretti, D.V, Fracassi, C, Pievani, M, Geroldi, C, Binetti, G, Zanetti, O, Sosta, K, Rossini, P.M, Frisoni, G.B

    Published in Clinical neurophysiology (01-02-2009)
    “…Abstract Objective In this study the theta/gamma ratio was investigated as early marker of cognitive decline. Methods Forty-nine subjects with mild cognitive…”
    Get full text
    Journal Article
  18. 18

    Hippocampal atrophy and EEG markers in subjects with mild cognitive impairment by Moretti, D.V, Miniussi, C, Frisoni, G.B, Geroldi, C, Zanetti, O, Binetti, G, Rossini, P.M

    Published in Clinical neurophysiology (01-12-2007)
    “…Abstract Objective The present study evaluates the potential relationship between hippocampal atrophy and EEG brain rhythmicity, as assessed by relative band…”
    Get full text
    Journal Article
  19. 19

    Patient classification and outcome prediction in IgA nephropathy by Diciolla, M, Binetti, G, Di Noia, T, Pesce, F, Schena, F.P, Vågane, A.M, Bjørneklett, R, Suzuki, H, Tomino, Y, Naso, D

    Published in Computers in biology and medicine (01-11-2015)
    “…Abstract Objective IgA Nephropathy (IgAN) is a common kidney disease which may entail renal failure, known as End Stage Kidney Disease (ESKD). One of the major…”
    Get full text
    Journal Article
  20. 20

    Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment by Ghidoni, R., Benussi, L., Glionna, M., Franzoni, M., Geroldi, D., Emanuele, E., Binetti, G.

    Published in Journal of Neural Transmission (01-07-2008)
    “…Growing evidence advanced the idea that the soluble form of the receptor for advanced glycation end-products (sRAGE) might serve as a risk marker for several…”
    Get full text
    Journal Article